(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (21) | 6 (14) | 7 (7) | 8 (3) | 9 (4) | < (49) | A (336) | B (71) | C (270) | D (140) | E (194) | F (157) | G (462) | H (72) | I (178) | J (46) | K (72) | L (87) | M (209) | N (154) | O (62) | P (276) | Q (10) | R (113) | S (502) | T (561) | U (134) | V (38) | W (308) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | ‘ (2) | “ (1)
Title Last update
32-9-2.5.2 Stop TB Global Drug Facility Diagnostics Catalog [.pdf] Fri, 01/27/2023 - 04:41
32-9-2.6 GDF_Technical_Information_Note_TBLAM [.pdf] Fri, 01/27/2023 - 04:44
32-9-2.7 GDF_Technical_Information_Note_TBLAMP [.pdf] Fri, 01/27/2023 - 04:44
32-9-2.8 GDF_Technical_Information_Note_Xpert [.pdf] Fri, 01/27/2023 - 04:44
32-9-2.9 Model Service Level Agreement for Xpert Surcharges v1 [.pdf] Fri, 01/27/2023 - 04:45
32-11.1 2018 Financial Management Report [.pdf] Fri, 01/27/2023 - 04:47
32-11.2 Narrative to the 2018 Financial Management Report [.pdf] Fri, 01/27/2023 - 04:48
32-11.3 Operating Principle for FPF_Diagnostics_Revised [.pdf] Fri, 01/27/2023 - 04:48
32-11.4 Operating Principle for FPF_Medicine_Revised [.pdf] Fri, 01/27/2023 - 04:49
32-11.5 Revised FPF Process Map - Diagnostics [.pdf] Fri, 01/27/2023 - 04:49
32-11.6 Revised FPF Process Map - Medicines [.pdf] Fri, 01/27/2023 - 04:49
30 Stop TB Board Decision Points_March 2018 [.pdf] Fri, 01/27/2023 - 09:22
30-0.1 StopTB Site Visit Registration_DEADLINE 13 February [.doc] Sun, 01/29/2023 - 05:20
30-0.2 Site Visits Program Overview [.pdf] Sun, 01/29/2023 - 05:20
30-0.1 Welcome and Practical information_Updated [.pdf] Sun, 01/29/2023 - 05:24
30-0.2 List of documents [.pdf] Sun, 01/29/2023 - 05:25
30-0.3 Provisional List of Participants_ 9 March 2018 [.pdf] Sun, 01/29/2023 - 05:25
30-1.1 Agenda_Stop TB Board meeting 2018 [.pdf] Sun, 01/29/2023 - 05:26
30-1.2 Report on DP actions from previous Board meeting final [.pdf] Sun, 01/29/2023 - 05:27
30-3.1 Report of the Executive Director [.pdf] Sun, 01/29/2023 - 06:06
30-3.2 Stop TB Partnership KPI Results 2017 [.pdf] Sun, 01/29/2023 - 06:06
30-4.1 WHO & StopTB Joint Initiative [.pdf] Sun, 01/29/2023 - 06:08
30-6.1 UNHLM_President of UNGA letter and Modalities Resolution [.pdf] Sun, 01/29/2023 - 06:09
30-7.1 Lancet TB Series_TB getting to zero [.pdf] Sun, 01/29/2023 - 06:10
30-7.2 The TB Activist Toolkit_An Activist Guide to Fighting TB [.pdf] Sun, 01/29/2023 - 06:11
30-7.3 What we need to fight TB_a list of demands to stop the TB epidemic [.pdf] Sun, 01/29/2023 - 06:11
30-9.1 ExecSummary - Global Report on Tuberculosis Vaccines 2018 [.pdf] Sun, 01/29/2023 - 06:12
30-9.2 TB Vaccines presentation -CEO AERAS [.pdf] Sun, 01/29/2023 - 06:13
30-11.2 Unitaid factsheet-tuberculosis-oct-2017-en [.pdf] Sun, 01/29/2023 - 06:14
30.11-1 Unitaid background document [.pdf] Sun, 01/29/2023 - 06:15
30-12.1 Annual Financial Management Report for 2017 [.pdf] Sun, 01/29/2023 - 06:16
30-12.2 Narrative to the 2017 Financial Management Report [.pdf] Sun, 01/29/2023 - 06:16
30-13.1 TB REACH Background Reading CB 2018 [.pdf] Sun, 01/29/2023 - 06:17
30-14.1 Comparative analysis of venue options [.pdf] Sun, 01/29/2023 - 06:17
31 Stop TB Board Decision Points [.pdf] Mon, 01/30/2023 - 03:09
31-01 Private sector landscape, need for quality & RM [.pdf] Mon, 01/30/2023 - 03:10